Atlas Trials

A Study of Imatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML)

Clinical trial NCT01011998 · WITHDRAWN

Trial details

NCT number
NCT01011998
Sponsor
New Mexico Cancer Research Alliance
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Myelogenous Leukemia
Start date
2009-09-01
Primary completion
2010-06-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.